ULTRACELL Trademark
Trademark Overview
On Monday, June 30, 2025, a trademark application was filed for ULTRACELL with the United States Patent and Trademark Office. The USPTO has given the ULTRACELL trademark a serial number of 99260614. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Thursday, February 12, 2026. This trademark is owned by Syenex, Inc.. The ULTRACELL trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
pharmaceutical and biopharmaceutical scientific research and development services using engineered viral vectors; product development for others relating to pharmaceuticals and biopharmaceuticals
pharmaceutical and biological preparations, namely, biological reagents, including nucleotide sequences, viral vectors, and plasmid kits comprising DNA buffers, nucleotide sequences, and viral vectors, all for medical use
manufacturing of pharmaceuticals and biopharmaceuticals for others
plasmid kits comprising DNA buffers for research use, nucleotide sequences for research use, and viral vectors for research use; viral vectors for research purposes, namely, virus-like particle vector preparations for use in gene therapy and medical and scientific research; pharmaceutical and biological preparations, namely, viral vectors for use in the manufacture of pharmaceuticals and biological preparations for use in the manufacture of pharmaceuticals
General Information
| Serial Number | 99260614 |
| Word Mark | ULTRACELL |
| Filing Date | Monday, June 30, 2025 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Thursday, February 12, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | pharmaceutical and biopharmaceutical scientific research and development services using engineered viral vectors; product development for others relating to pharmaceuticals and biopharmaceuticals |
| Goods and Services | pharmaceutical and biological preparations, namely, biological reagents, including nucleotide sequences, viral vectors, and plasmid kits comprising DNA buffers, nucleotide sequences, and viral vectors, all for medical use |
| Goods and Services | manufacturing of pharmaceuticals and biopharmaceuticals for others |
| Goods and Services | plasmid kits comprising DNA buffers for research use, nucleotide sequences for research use, and viral vectors for research use; viral vectors for research purposes, namely, virus-like particle vector preparations for use in gene therapy and medical and scientific research; pharmaceutical and biological preparations, namely, viral vectors for use in the manufacture of pharmaceuticals and biological preparations for use in the manufacture of pharmaceuticals |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 11, 2026 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 30, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 30, 2025 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 30, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Syenex, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Evanston, IL 60201 |
Trademark Events
| Event Date | Event Description |
| Monday, June 30, 2025 | NEW APPLICATION ENTERED |
| Monday, June 30, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, November 5, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, November 10, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, November 12, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, November 12, 2025 | NON-FINAL ACTION E-MAILED |
| Wednesday, November 12, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, February 11, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, February 11, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, February 11, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, February 12, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, February 12, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, February 12, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, February 12, 2026 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, February 12, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
